Nitric oxide and inflammatory joint diseases

British Journal of Rheumatology

Volumn 37, Issue 3, 1998, Pages 246-257

  Stichtenoth, D O ^a   Frolich J C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Inflammatory joint disease; Isoenzymes; Metabolism; Nitric oxide; Nitric oxide synthase; Treatment

Indexed keywords

ARGININE; CYTOKINE; ENDOTOXIN; GLUCOCORTICOID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTHRITIS; BACTERICIDAL ACTIVITY; CARDIOVASCULAR FUNCTION; CYTOTOXICITY; DISEASE ACTIVITY; ENZYME INHIBITION; HOMEOSTASIS; NERVE CELL; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY;

EID: 0347963849     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.3.246     Document Type: Review

References (168)

1. Mitchell HH, Shoule HA, Grindley HS. The origin of the nitrates in the urine. J Biol Chem 1916;24:461-90.
2. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
3. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985;82:7738-42.
4. Hibbs JB Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role of L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987;235:473-6.
5. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;28:373-6.
6. Förstermann U, Mülsch A, Böhme E, Busse R. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 1986;58:531-8.
7. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′: 5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 1977;74:3203-7.
8. Green LC, Tannenbaum SR, Goldman R. Nitrate synthesis in the germfree and conventional rat. Science 1981;212:56-8.
9. Green LC, Ruiz de Luzuriaga K, Wagner DA et al. Nitrate biosynthesis in man. Proc Natl Acad Sci USA 1981;78:7764-8.
10. 3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 1983;80:4518-21.
11. Iyengar R, Stuehr DJ, Marletta MA. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA 1987;84:6369-73.
12. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
13. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9.
14. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87-94.
15. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988;336:385-8.
16. Koshland DE. The molecule of the year. Science 1992;258:1861.
17. Schmidt HHHW, Nau H, Wittfoht W et al. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol 1988;154:213-6.
18. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
19. 2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum. FEBS Lett 1990;277:215-9.
20. Bredt SD, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles P-450 reductase. Nature 1991;351:714-8.
21. Schmidt HHHW, Pollock JS, Nakane M, Gorsky LD, Förstermann U, Murad F. Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc Natl Acad Sci USA 1991;88:365-9.
22. Pollock JS, Förstermann U, Mitchell JA et al. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991;88:10480-4.
23. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992;267:14519-22.
24. Sessa WC, Harrison JK, Barber CM et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 1992;267:15274-6.
25. Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I et al. Nitric oxide isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-31.
26. Yui Y, Hattori R, Kosuga K, Eizawa H, Hiki K, Kawai C. Purification of nitric oxide synthase from rat macrophages. J Biol Chem 1991;266:12544-7.
27. Xie QW, Cho HJ, Calaycay J et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256:255-8.
28. Lyons CL, Orloff GJ, Cunningham JM. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 1992;267:6370-4.
29. Chartrain NA, Geller DA, Koty PP et al. Molecular cloning, structure and chromosomal localization of the human inducible nitric oxide synthase. J Biol Chem 1994;269:6765-72.
30. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994;298:249-58.
31. Weinberg JB, Misukonis MA, Shami PJ et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995;86:1184-95.
32. Wright CD, Mulsch A, Busse R, Oswald H. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989;160:813-9.
33. Wheeler MA, Smith SD, Garcia-Cardena G, Nathan CF, Weiss RM, Sessa WC. Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest 1997;99:110-6.
34. Curran RD, Billiar TR, Stuehr DJ, Hofmann K, Simmons RL. Hepatocytes produce nitric oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989;170:1769-74.
35. Nussler AK, Di Silvio M, Biliar TR et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 1992;176:261-6.
36. Beasley D, Schwartz JH, Brenner BM. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991;87:602-8.
37. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1 or endotoxin. J Natl Cancer Inst 1990;82:772-6.
38. Hibbs JB Jr, Westenfelder C, Taintor R et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992;89:867-77.
39. Marsden PA, Ballermann PJ. Tumor necrosis factor α activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J Exp Med 1990;172:1843-52.
40. Drapier J-C, Wietzerbin J, Hibbs JB Jr. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988;18:1587-92.
41. Al-Ramadi BK, Meissler JJ, Huang D, Eisenstein TK. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur J Immunol 1992;22:2249-54.
42. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992;148:3578-82.
43. McCall TB, Palmer RMJ, Moncada S. Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochem Biophys Res Commun 1991;186:680-5.
44. Doherty TM, Kastelein R, Menson S, Andrade S, Coffman RL. Modulation of murine macrophage function by IL-13. J Immunol 1993;151:7151-60.
45. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1, -beta 2, -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFNγ. J Immunol 1990;145:940-4.
46. Di Rosa M, Radomski M, Carnuccio R, Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 1990;172:1246-52.
47. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-7.
48. Kwon NS, Nathan CF, Stuehr DJ. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 1989;264:20496-501.
49. Pollock JS, Werner ER, Mitchell JA, Förstermann U. Particulate endothelial nitric oxide synthase: requirement and content of tetrahydrobiopterin, FAD and FMN. Endothelium 1993;1:147-52.
50. Mayer B, John M, Heinzel B et al. Brain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductase. FEBS Lett 1991; 288:187-91.
51. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 1991;88:7773-7.
52. Cho HJ, Xie QW, Calaycay J et al. Calmodulin as a tightly bound subunit of calcium-, calmodulin-independent nitric oxide synthase. J Exp Med 1992;176:599-604.
53. Geller DA, Lowenstein CJ, Shapiro RA et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-5.
54. Palmer RMJ, Andrews T, Foxwell NA, Moncada S. Glucocorticoids do not affect the induction of a novel calcium-dependent nitric oxide synthase in rabbit chondrocytes. Biochem Biophys Res Commun 1992; 188:209-15.
55. Amin AR, Di Cesare PE, Vyas P et al. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: Evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 1995;182:2097-102.
56. Pfeilschifter J, Eberhardt W, Hummel R, Kunz D, Mühl H, Nitsch D et al. Therapeutic strategies for the inhibition of inducible nitric oxide synthase-potential for a novel class of anti-inflammatory agents. Cell Biol Int 1996;20:51-8.
57. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991;41:485-90.
58. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986;78:1-5.
59. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
60. Drapier J-C, Hibbs JB. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 1988;140:2829-38.
61. Tamir S, Burney S, Tannenbaum SR. DNA damage by nitric oxide. Chem Res Toxicol 1996;9:821-7.
62. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
63. Reif DW, Simmons RD. Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys 1990;283:537-41.
64. Frölich JC. Prostaglandin endoperoxide synthetase isoenzymes: the clinical relevance of selective inhibition. Ann Rheum Dis 1995;54:942-3.
65. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG, Needleman P: Regulation of prostaglandin production by nitric oxide; an in vivo analysis. Br J Pharmacol 1995;114:1171-8.
66. Vane JR, Botting RM. Overview - mechanism of action of anti-inflammatory drugs. In: Vane J, Botting J, Botting R, eds. Improved non-steroid anti-inflammatory drugs. COX-2 enzyme inhibitors. Dordrecht: Kluwer Academic, 1996:1-27.
67. Wennmalm A, Benthin G, Peterson A-S. Dependence of the melabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell hemoglobin. Br J Pharmacol 1992;106:507-8.
68. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996;380:221-6.
69. Tsikas D, Rossa S, Stichtenoth DO, Raida M, Gutzki F-M, Frölich JC. Is S-nitroso-N-acetyl-L-cysteine a circulating or an excretory metabolite of nitric oxide (NO) in man? Assessment by gas chromatographymass spectrometry. Biochem Biophys Res Commun 1996;220:939-4.
70. Wennmalm A, Benthin G, Jungersten L, Edlund A, Petersson A-S. Nitric oxide formation in man as reflected by plasma levels of nitrate, with special focus on kinetics, confounding factors, and response to immunological challenge. Endothelium 1993; 1(suppl.):84.
71. Farrell AJ, Blake DR, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
72. 3 excretion in the urine as an indicator of endothelium-derived relaxing factor during elevation of blood pressure. Clin Sci 1992; 82:631-4.
73. Bode-Böger SM, Böger RH, Creutzig A et al. L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci 1994;87:303-10.
74. Radomski JL, Palmiri C, Hearn WL. Concentrations of nitrate in normal human urine and the effect of nitrate ingestion. Toxicol Appl Pharmacol 1978;45: 63-8.
75. Tsikas D, Gutzki F-M, Rossa S et al. Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay - solutions by gas chromatography-mass spectrometry. Anal Biochem 1997;244:208-20.
76. Griess P. Bemerkungen zu der Abhandlung der H.H. Weselsky und Benedikt 'Über einige Azoverbindungen'. Ber Dtsch Chem Ges 1879;12:426-8.
77. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
78. 15N-labelled analogs. J Chromatogr B 1994;661:185-91.
79. Cook HT, Cattell V. Role of nitric oxide in immune-mediated diseases. Clin Sci 1996;91:375-84.
80. Malawista SE, Montgomery RR, van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes. J Clin Invest 1992;90:631-6.
81. Green SJ, Scheller LB, Marietta MA et al. Nitric oxide: Cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol Lett 1994;43:87-94.
82. James SL, Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J Immunol 1989;143:4208-12.
83. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989;169:1543-55.
84. Ialenti A, Ianaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992;211:177-82.
85. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide mediated apoptosis in murine macrophages. J Immunol 1993;150:5080-5.
86. Albina JE, Abate JA, Henry WL Jr. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J Immunol 1991; 147:144-8.
87. Merryman PF, Clancy RM, He XY, Abramson SB. Modulation of human T cell responses by nitric oxide and its derivative, S-nitrosoglutathione. Arthritis Rheum 1993;36:1414-22.
88. Belenky SN, Robbins RA, Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukocyte Biol 1993;53:498-503.
89. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
90. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993;7:1293-9.
91. Stadler J, Harbrecht BG, Di Silvio M et al. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat kupffer cells. J Leukocyte Biol 1993;53:165-72.
92. Hogaboam CM, Befus AD, Wallace JL. Modulation of mast cell reactivity by IL-1-beta. Divergent effects on nitric oxide and platelet-activating factor release. J Immunol 1993;151:3767-74.
93. Salvemini D, Masini E, Pistelli A, Mannaioni PF, Vane J. Nitric oxide: a regulatory mediator of mast cell reactivity. J Cardiovasc Pharmacol 1991; 17(suppl. 3):S258-64.
94. Miller MJS, Clark DA. Nitric oxide synthase inhibition can initiate or prevent gut inflammation: role of enzyme source. Agents Actions 1994;41:C231-2.
95. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukocyte Biol 1990;48:565-9.
96. Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billiar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994;266:G1004-10.
97. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arthritis Rheum 1993;36:1036-44.
98. Miller MJS, Chotinaruemol S, Sadowska-Krowicka H et al. Nitric oxide: The Jekyll and Hyde of gut inflammation. Agents Actions 1993;39:C180-2.
99. Stichtenoth DO, Gutzki F-M, Tsikas D et al. Increased urinary nitrate excretion in rats with adjuvant arthritis. Ann Rheum Dis 1994;53:547-9.
100. Stichtenoth DO, Osthaus WA, Frölich JC. Inhibition of nitric oxide synthesis is as effective as dexamethasone in treatment of adjuvant arthritis. Br J Pharmacol 1995;116(suppl.):90P.
101. Oyanagui Y. Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats. Life Sci 1994;54:285-9.
102. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994;37:1062-9.
103. Ialenti A, Moncada S, Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. J Pharmacol 1993;110:701-6.
104. McCartney-Francis N, Allen JB, Mizel DE et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
105. Connor JR, Manning PT, Settle SL et al. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 1995;273:15-24.
106. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. Comparison of the nitric oxide synthase inhibitors methylarginine and amino-guanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 1995;22:1922-8.
107. Zidek Z, Frankova D, Otova B. Lack of causal relationship between inducibility/severity of adjuvant arthritis in the rat and disease associated changes in production of nitric oxide by macrophages. Ann Rheum Dis 1995;54:325-7.
108. Cannon GW, Remmers EF, Wilder RL, Hibbs JB Jr, Griffiths MM. Nitric oxide production during adjuvant-induced arthritis is associated with tumor necrosis factor genotype. Transplant Proc 1995;27:1543-4.
109. Cannon GW, Openshaw SJ, Hibbs JB Jr et al. Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheum 1996;39:1677-84.
110. Miesel R, Kurpisz M, Kröger H. Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase. Free Radical Biol Med 1996;20:75-81.
111. Kanno K, Hirata Y, Emori T et al. L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992;19:619-25.
112. Bode-Böger SM, Böger RH, Alfke H et al. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. Circulation 1996;93:85-90.
113. Stichtenoth DO, Fauler J, Zeidler H, Frölich JC. Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis 1995;54:820-4.
114. Grabowski PS, England AJ, Dykhuizen R et al. Elevated nitric oxide production in rheumatoid arthritis. Arthritis Rheum 1996;39:643-7.
115. Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996;23:230-6.
116. Dougados M, Van der Linden S, Juhlin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
117. Stichtenoth DO, Wollenhaupt J, Andersone D, Zeidler H, Frölich JC. Elevated serum nitrate concentrations in active spondyloarthropathies. Br J Rheumatol 1995;34:616-9.
118. Kaur H, Halliwell B. Evidence for nitric oxide-mediated damage in chronic inflammation - Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9-12.
119. Van der Vliet A, O'Neill CA, Halliwell B, Kaur H. Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite - evidence for hydroxyl radical production from peroxynitrite. FEBS Lett 1994;339:89-92.
120. G-monomethyl-L-arginine. J Exp Med 1994;179:651-60.
121. Buyon JP, Seligman S, Clancy R, Belmont HM, Young B, Abramson S. Increased serum nitrite levels in lupus pregnancies. Arthritis Rheum 1994; 37(suppl.):S324.
122. Panayi GS. The immunopathogenesis of rheumatoid arthritis. Br J Rheumatol 1993;32(suppl. 1):4-14.
123. Nouri AME, Panayi GS, Goodman SM. Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 1984;55:295-302.
124. McInnes IB, Leung BP, Field M et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996; 184:1519-24.
125. Sakurai H, Kohsaka H, Liu M-F et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritis. J Clin Invest 1995; 96:2357-63.
126. St. Clair EW, Wilkinson WE, Lang T et al. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med 1996;184:1173-8.
127. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994;135:330-6.
128. Maier R, Geng Y, Zhang B, Rediske J, Bilbe G, Lotz M. Inducible nitric oxide synthesis in human joint tissue cells. Endothelium 1993;1(suppl.):s48.
129. Charles IG, Palmer RMJ, Hickery MS et al. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase in human chondrocytes. Proc Natl Acad Sci USA 1993;90:11419-23.
130. Palmer RMJ, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993; 193:398-405.
131. Rediske J, Koehne C, Zhang B, Lotz M. Human articular chondrocytes induced by proinflammatory mediators are the major articular cell source of nitric oxide. Osteoarthritis Cartilage 1994;2:199-206.
132. Hayashi T, Abe E, Yamate T, Taguchi Y, Jasin HE. Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 1997;40:261-9.
133. Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukocyte Biol 1995;58:643-9.
134. Zembala M, Siedlar M, Marcinkiewicz J, Pryjma J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol 1994;24:435-9.
135. Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukocyte Biol 1991;49:380-7.
136. De Maria R, Cifone MG, Trotta R et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994;180:1999-2004.
137. MacIntyre I, Zaidi M, Towhidul Alam ASM et al. Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 1991;88:2936-40.
138. Stefanovic-Racic M, Morales TI, Taskiran D, McIntyre LA, Evans CH. The role of nitric oxide in proteoglycan turnover by bovine articular organ cultures. J Immunol 1996;156:1213-20.
139. Ralston SH, Helfrich M, Grabowski PS, Benjamin N. A role for nitric oxide in the regulation of cytokine-induced bone resorption. J Bone Miner Res 1993; 8(suppl. 1):383.
140. Ralston SH, Todd D, Helfrich M, Grabowski PS, Benjamin N. Nitric oxide: a cytokine-induced osteoblast product with stimulatory effects on bone resorption. Endothelium 1993;1(suppl.):s10.
141. Hukkanen M, Hughes F, Springall DR, Riveros-Moreno V, Moncada S, Polak JM. Osteoblasts express inducible NO synthase which in turn mediates osteoblast function. Endothelium 1993;1(suppl.):s11.
142. Häuselmann HJ, Oppliger L, Michel BA, Stefanovic-Racic M, Evans CH. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett 1994;352:361-4.
143. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
144. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146:75-85.
145. Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology 1993;104:759-71.
146. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993;341:465-6.
147. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995;36:718-23.
148. Sasajima K, Yoshida Y, Yamakado S et al. Changes in urinary nitrate and nitrite during treatment of ulcerative colitis. Digestion 1996;57:170-3.
149. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-5.
150. Kobzik L, Bredt DS, Lowenstein CJ et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993;9:371-7.
151. Winklhofer F, Dai F-X, Skopec J et al. Nitric oxide production in renal allograft recipients: effects of acute rejection and cyclosporine (CSA). J Am Soc Nephrol 1995;6:1122.
152. Worrall NK, Lazenby WD, Misko TB et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995;181:63-70.
153. Kolb H, Kiesel U, Kröncke KD, Kolb-Bachofen V. Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. Life Sci 1991;49:PL213-7.
154. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 1994;93:2684-90.
155. Ketteler M, Border WA, Noble NA. Cytokines and L-arginine in renal injury and repair. Am J Physiol 1994;267:F197-207.
156. Ferrario R, Takahashi K, Fogo A, Badr KF, Munger KA. Consequences of acute nitric oxide synthesis inhibition in experimental glomerulonephritis. J Am Soc Nephrol 1994;4:1847-54.
157. Kunz D, Walker G, Pfeilschifter J. Dexamethasone differentially affects interleukin 1β- and cyclic AMP-induced nitric oxide synthase mRNA expression in renal mesangial cells. Biochem J 1994;304:337-40.
158. Mühl H, Kunz D, Rob P, Pfeilschifter J. Cyclosporin derivatives inhibit interleukin 1β induction of nitric oxide synthase in renal mesangial cells. Eur J Pharmacol 1993;49:95-100.
159. Aeberhard EE, Henderson SA, Arabolos NS et al. Nonsteroidal anti-inflammatory drugs inhibit expres-sion of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995;208:1053-9.
160. Kepka-Lenhart D, Chen L-C, Morris SM Jr. Novel actions of aspirin and sodium salicylate: discordant effects on nitric oxide synthesis and induction of nitric oxide synthase mRNA in a murine macrophage cell line. J Leukocyte Biol 1996;59:840-6.
161. Grisham MB, Miles AM. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. Biochem Pharmacol 1994;47:1897-902.
162. Stichtenoth DO, Alz R, Nolte I, Frölich JC. 5-aminosalicylic acid reduces nitric oxide synthesis and disease activity in adjuvant arthritic rats. Eur J Clin Pharmacol 1997;52:A6.
163. Gyllenhammar H, Lärfars G, Bratt J, Palmblad J. Antirheumatic gold salts inhibit production of nitric oxide in murine macrophages activated with lipopolysaccharide. J Invest Med 1996;44:298A.
164. Mayer B, Werner ER. In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 351:453-63.
165. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertension 1993; 11:1375-80.
166. Brüne B, Lapetina EG. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J Biol Chem 1989;264:8455-8.
167. Brüne B, Dimmeler S, Molina y Vedia L, Lapetina EG. Nitric oxide: a signal for ADP-ribosylation of proteins. Life Sci 1994;54:61-70.
168. Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991;174:761-8.